Patients who achieved inadequate results on tirzepatide and want a mechanistically distinct option
We partnered with PWS patient organizations to develop a discrete-choice experiment exploring caregivers benefit-risk tradeoffs for emerging PWS treatments
Novo Nordisk initially developed the first GLP-1 RA, liraglutide, as a type-2 diabetes treatment
Wall Street appeared to favor Lilly's expanding clinical pipeline over Novo's commercial momentum, highlighting the growing competition between the two pharmaceutical giants that dominate the GLP-1 obesity market
My wife ended up calling this mobile iv nurse to come to the house, and this angel of a man named Gabriel came and not only gave me the iv but advise on other things I could do on an empty stomach to ease all the horrible symptoms I had
For most GLP-1 weight management medications, Anthem requires a BMI of 30 or greater (clinical obesity) or a BMI of 27 or greater with at least one weight-related comorbidity